It is known that KL is involved in various biological processes and inhibits the insulin-like growth factor (IGF-1) signaling pathway5, which may be associated with malignancies of non-small-cell lung carcinoma (NSCLC) and small-cell carcinoma (SCLC)6. The gene discussed is KL; the disease is non-small cell lung carcinoma.